LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $1,775,380,496
Key CONT_AWD_75N91020F00003_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 79 days before this system saw it. One version on record.
Cite this row
On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91020F00003_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:18Z
Content hash
f31cf150cd1e70c562fa164ee0ed261a5467d96f7c7b7b01eedd952338ec1d77The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $1,775,380,496 | first version | August 31, 2020 | June 18, 2026 | 2026-09-05T00:54:18Z | historical sweep | f31cf150cd1e |
Archived copy
https://web.archive.org/web/20261007033646/https://www.usaspending.gov/award/CONT_AWD_75N91020F00003_7529_75N91019D00024_7529/ found, made by someone else, October 7, 2026
What the amount is made of
46 recorded actions, so the amount is the award's current total across all of them. 38 of them obligated money. Measured 2026-10-13, when USAspending reported a total obligation of $1,775,380,496.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 18, 2026 | P00045 | FUNDING ONLY ACTION | −$10,806 | FY26 UDO INITIATIVE - NCI OPERATIONAL TASK ORDER FY20 - FY23 |
| September 6, 2024 | P00044 | FUNDING ONLY ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 31, 2024 | P00043 | OTHER ADMINISTRATIVE ACTION | +$29,234,640 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 27, 2024 | P00042 | FUNDING ONLY ACTION | +$33,374,328 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 13, 2024 | P00041 | FUNDING ONLY ACTION | −$11,366,887 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| July 19, 2024 | P00040 | OTHER ADMINISTRATIVE ACTION | +$7,359,436 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| June 26, 2024 | P00039 | OTHER ADMINISTRATIVE ACTION | +$40,094,642 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| May 24, 2024 | P00038 | OTHER ADMINISTRATIVE ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| May 6, 2024 | P00037 | OTHER ADMINISTRATIVE ACTION | +$57,991,599 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| April 2, 2024 | P00036 | OTHER ADMINISTRATIVE ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| March 7, 2024 | P00035 | OTHER ADMINISTRATIVE ACTION | +$621,412 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| December 21, 2023 | P00034 | OTHER ADMINISTRATIVE ACTION | +$184,814 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| October 24, 2023 | P00033 | OTHER ADMINISTRATIVE ACTION | +$53,739 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| September 28, 2023 | P00032 | FUNDING ONLY ACTION | +$238,382,107 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 30, 2023 | P00031 | EXERCISE AN OPTION | +$69,102,452 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 18, 2023 | P00030 | OTHER ADMINISTRATIVE ACTION | +$7,688,748 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 4, 2023 | P00029 | FUNDING ONLY ACTION | +$19,391,416 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| July 18, 2023 | P00028 | FUNDING ONLY ACTION | +$12,900,000 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| June 23, 2023 | P00027 | FUNDING ONLY ACTION | +$15,100,600 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| June 6, 2023 | P00026 | FUNDING ONLY ACTION | +$28,845,070 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| March 31, 2023 | P00025 | FUNDING ONLY ACTION | +$61,155,563 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| March 20, 2023 | P00024 | OTHER ADMINISTRATIVE ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| December 19, 2022 | P00023 | OTHER ADMINISTRATIVE ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| September 28, 2022 | P00022 | FUNDING ONLY ACTION | +$226,662,708 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 30, 2022 | P00021 | EXERCISE AN OPTION | +$63,802,858 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 19, 2022 | P00020 | FUNDING ONLY ACTION | +$15,797,534 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| July 28, 2022 | P00019 | OTHER ADMINISTRATIVE ACTION | +$21,210,428 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| June 30, 2022 | P00018 | FUNDING ONLY ACTION | +$27,442,800 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| May 31, 2022 | P00017 | OTHER ADMINISTRATIVE ACTION | no money | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| May 20, 2022 | P00016 | FUNDING ONLY ACTION | +$59,982,927 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| May 19, 2022 | P00015 | OTHER ADMINISTRATIVE ACTION | −$1,590,212 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| November 15, 2021 | P00014 | OTHER ADMINISTRATIVE ACTION | no money | NCI OPERATIONAL TASK ORDER. |
| September 28, 2021 | P00013 | FUNDING ONLY ACTION | +$205,696,815 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| September 3, 2021 | P00012 | OTHER ADMINISTRATIVE ACTION | −$1,414,661 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 27, 2021 | P00011 | EXERCISE AN OPTION | +$90,840,235 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 17, 2021 | P00010 | OTHER ADMINISTRATIVE ACTION | +$24,886,601 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| August 2, 2021 | P00009 | FUNDING ONLY ACTION | +$16,620,261 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH THE IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| June 23, 2021 | P00008 | OTHER ADMINISTRATIVE ACTION | +$36,226,692 | NCI OPERATIONAL TASK ORDER |
| June 2, 2021 | P00007 | OTHER ADMINISTRATIVE ACTION | +$2,626,906 | NCI OPERATIONAL TASK ORDER |
| March 24, 2021 | P00006 | FUNDING ONLY ACTION | +$75,021,989 | NCI OPERATIONAL TASK ORDER |
| March 16, 2021 | P00005 | OTHER ADMINISTRATIVE ACTION | +$800,000 | NCI OPERATIONAL TASK ORDER |
| January 21, 2021 | P00004 | OTHER ADMINISTRATIVE ACTION | +$1,283,576 | NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT |
| November 12, 2020 | P00003 | OTHER ADMINISTRATIVE ACTION | +$400,000 | NCI OPERATIONAL TASK ORDER |
| September 27, 2020 | P00002 | FUNDING ONLY ACTION | +$207,226,867 | NCI OPERATIONAL TASK ORDER |
| September 4, 2020 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | NCI OPERATIONAL TASK ORDER |
| August 31, 2020 | base | not on file | +$91,753,299 | NCI OPERATIONAL TASK ORDER |
Last refreshed November 4, 2026 at 2:31 PM UTC.